Lack of Significant Drug Interactions for Sumanirole in Phase II Studies Using Population Pharmacokinetic (PPK) Methods

Lack of Significant Drug Interactions for Sumanirole in Phase II Studies Using Population Pharmacokinetic (PPK) Methods

Conference: AAPS

Sumanirole is a highly D2-selective dopamine receptor agonist that is in development for the treatment of Parkinson's disease (PD). Metabolism of sumanirole and in vitro data indicate that…

Evaluation of the Relationship Between Sumanirole Exposure and Orthostatic Hypotension

Evaluation of the Relationship Between Sumanirole Exposure and Orthostatic Hypotension

Conference: AAPS

Sumanirole is a selective D2 receptor agonist in development for treatment of Parkinson's disease (PD). This agent is expected to have a better safety profile compared to other dopaminergic agents…

Pharmacokinetics/Pharmacodynamics in Otitis Media: Comparison of Time-Dependent Antibiotics in Middle Ear Fluid

Pharmacokinetics/Pharmacodynamics in Otitis Media: Comparison of Time-Dependent Antibiotics in Middle Ear Fluid

Conference: IDSA

An effective dosing regimen of b-lactam and macrolide antibiotics for otitis media involving S. pneumoniae (SP) requires that drug concentrations in middle ear fluid (MEF) remain above the MIC (T>MIC)…

Population Pharmacokinetics (PK) Of Linezolid In Neonates And Young Infants

Population Pharmacokinetics (PK) Of Linezolid In Neonates And Young Infants

Conference: ICAAC

Linezolid (LZD) is the first approved oxazolidinone antibiotic and has shown broad activity against gram-positive bacteria, including VRE and MRSA. Previous studies indicated LZD clearance was higher in…

Rule Extraction from a Mutagenicity Data Set Using Adaptively Grown Phylogenetic-like Trees

Rule Extraction from a Mutagenicity Data Set Using Adaptively Grown Phylogenetic-like Trees

Publication: J Chem Inf Model
Software: MedChem Studio™

A public bacterial mutagenicity database was classified into 2-D structural families using a set of specific algorithms and clustering techniques that find overlapping...

A New Paradigm of Real-Time Data Assembly to Support Knowledge-Based Decision Making: A Case Study

A New Paradigm of Real-Time Data Assembly to Support Knowledge-Based Decision Making: A Case Study

Conference: DIA

Real-time data assembly (RTDA) to support knowledgebased decision making was implemented for the development of a compound during Phase II. Program goals were to develop a data warehouse to expedite…

Comparison of Post-Operative Nosocomial Infection Associated with Blood Management Techniques in Cardiovascular and Orthopedic Surgery

Comparison of Post-Operative Nosocomial Infection Associated with Blood Management Techniques in Cardiovascular and Orthopedic Surgery

Conference: DIA

Numerous risks are associated with allogeneic blood transfusions, however non-allogeneic blood options can minimize the use of allogeneic blood. This study compared infection rates associated with blood…

Data Analysis of High-Throughput Screening Results:  Application of Multidomain Clustering to the NCI Anti-HIV Data Set

Data Analysis of High-Throughput Screening Results:  Application of Multidomain Clustering to the NCI Anti-HIV Data Set

Publication: J Med Chem
Software: MedChem Studio™

The routine use of high-throughput screening (HTS) systems in the drug discovery process has resulted in an increasing need for fast, reliable analysis of massive amounts of data.

Rapid Assessment of Data Set Structures

Rapid Assessment of Data Set Structures

Authors: Vecchione P
Conference: Pharmaceutical Industry SAS Users Group (PharmaSUG)

When SAS® data is received from an external source, such as a sponsor, CRO, or another department, it is important to assess the new data to determine if variables have been added or removed, locate…

Simultaneous Population Pharmacokinetic (PBK) Modeling of Irinotecan (CPT-11) and its Major Metabolites, SN 38 and SN-38G

Simultaneous Population Pharmacokinetic (PBK) Modeling of Irinotecan (CPT-11) and its Major Metabolites, SN 38 and SN-38G

Conference: ASCPT

To develop a PPK model in NONMEM® that simultaneously predicts the plasma concentration (Cp) profiles of CPT-11 (C) and its metabolites, SN-38 (S) and SN-38G (G).